Watson Pharmaceuticals (WPI) Tops Q2 EPS by 8c, Guides In-line for FY; Announces CEO Succession Plan
Tweet Send to a Friend
Watson Pharmaceuticals, Inc. (NYSE: WPI) reoprts Q2 EPS of $0.34 (ex-items), 8 cents better than estimates. Revenues were $603.0 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
